SCHEMBL7016513

SCHEMBL7016513

Cc1cc(N2CCN(C(=O)OCc3ccccc3)C(CC(=O)OC(C)(C)C)C2)ccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 2/20 0.48
▸ NR1H3 Q13133 2/20 0.48
▸ PDK1 Q15118 1/20 0.42
▸ PDK2 Q15119 1/20 0.42
▸ PDK3 Q15120 1/20 0.42
▸ PDK4 Q16654 1/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ SIGMAR1 Q99720 9/20 0.41
▸ TMEM97 Q5BJF2 8/20 0.41
▸ DPP4 P27487 1/20 0.41
▸ TP53 P04637 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ ADRA1D P25100 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ ADRA1B P35368 1/20 0.39
▸ THPO P40225 1/20 0.39
▸ HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010020 0.90 SIGMAR1 (0.46) SIGMAR1TMEM97ADRA1DSLC6A3
SCHEMBL7016352 0.89 SIGMAR1 (0.45) NR1H2NR1H3PDK1PDK2PDK3
SCHEMBL7020197 0.86 SIGMAR1 (0.42) NR1H2NR1H3SIGMAR1TMEM97HDAC1
SCHEMBL7013241 0.86 SIGMAR1 (0.42) NR1H2NR1H3SIGMAR1TMEM97HDAC1
SCHEMBL7016082 0.80 NPSR1 (0.46) NR1H2NR1H3SIGMAR1TMEM97TP53
SCHEMBL21590367 0.76 NR1H2 (0.51) NR1H2NR1H3PDK1PDK2PDK3
SCHEMBL21594457 0.76 NR1H2 (0.51) NR1H2NR1H3PDK1PDK2PDK3
SCHEMBL7010091 0.76 NR1H2 (0.41) NR1H2NR1H3
SCHEMBL30554118 0.74 PARP1 (0.45) NR1H2NR1H3PDK1PDK2PDK3
SCHEMBL30554121 0.74 PARP1 (0.45) NR1H2NR1H3PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 — — US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof SULT1E1, RRS1, SHH NR1H2 330/4885NR1H3 534/4885PDK1 4505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback